214 related articles for article (PubMed ID: 8078640)
1. Clinical evaluation of hypertrophic cardiomyopathy by myocardial scintigraphy using 123I-labelled 15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid (123I-BMIPP).
Ohtsuki K; Sugihara H; Umamoto I; Nakamura T; Nakagawa T; Nakagawa M
Nucl Med Commun; 1994 Jun; 15(6):441-7. PubMed ID: 8078640
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of 123I-BMIPP myocardial scintigraphy in patients with hypertrophic cardiomyopathy].
Ohtsuki K; Sugihara H; Umamoto I; Harada Y; Shiga K; Nakamura T; Nakagawa T; Azuma A; Kohno Y; Katsume H
Kokyu To Junkan; 1992 Feb; 40(2):175-81. PubMed ID: 1565884
[TBL] [Abstract][Full Text] [Related]
3. 123I-labelled BMIPP fatty acid myocardial scintigraphy in patients with hypertropic cardiomyopathy: SPECT comparison with stress 201Tl.
Taki J; Nakajima K; Bunko H; Shimizu M; Taniguchi M; Hisada K
Nucl Med Commun; 1993 Mar; 14(3):181-8. PubMed ID: 8455908
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy.
Takeishi Y; Chiba J; Abe S; Tonooka I; Komatani A; Tomoike H
Eur J Nucl Med; 1992; 19(9):775-82. PubMed ID: 1396872
[TBL] [Abstract][Full Text] [Related]
5. Myocardial metabolism of 123I-BMIPP in patients with hypertrophic cardiomyopathy: assessment by radial long-axis SPET.
Chen SL; Uehara T; Morozumi T; Yamagami H; Kusuoka H; Nishimura T
Nucl Med Commun; 1995 May; 16(5):336-43. PubMed ID: 7659385
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of 123I-BMIPP myocardial SPECT in patients with hypertensive heart disease and hypertrophic cardiomyopathy: comparison with the findings of 201Tl SPECT and Gd enhanced magnetic resonance imaging].
Miyanaga H; Kawasaki S; Yoneyama S; Hyougo T; Kamitani T; Takahashi T; Kunishige H
Kaku Igaku; 1997 Feb; 34(2):85-93. PubMed ID: 9095571
[TBL] [Abstract][Full Text] [Related]
7. [Is myocardial fatty acid metabolism different between hypertrophic cardiomyopathy and hypertensive hypertrophy?].
Narita M; Kurihara T; Usami M; Honda M
Kaku Igaku; 1994 Dec; 31(12):1465-76. PubMed ID: 7861646
[TBL] [Abstract][Full Text] [Related]
8. [Fatty acid metabolic and perfusion abnormalities in hypertrophied myocardium assessed by dual tracer tomography using thallium-201 and iodine-123-beta-methylpentadecanoic acid].
Kobayashi H; Nakata T; Han S; Takahashi N; Hashimoto A; Tsuchihashi K; Nagao K; Tanaka S; Shimamoto K; Iimura O
J Cardiol; 1994; 24(1):35-43. PubMed ID: 8158529
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography.
Nishimura T; Nagata S; Uehara T; Morozumi T; Ishida Y; Nakata T; Iimura O; Kurata C; Wakabayashi Y; Sugihara H; Otsuki K; Wada T; Koga Y
Ann Nucl Med; 1996 Feb; 10(1):71-8. PubMed ID: 8814730
[TBL] [Abstract][Full Text] [Related]
10. Impairment of regional fatty acid uptake in relation to wall motion and thallium-201 uptake in ischaemic but viable myocardium: assessment with iodine-123-labelled beta-methyl-branched fatty acid.
Taki J; Nakajima K; Matsunari I; Bunko H; Takada S; Tonami N
Eur J Nucl Med; 1995 Dec; 22(12):1385-92. PubMed ID: 8586083
[TBL] [Abstract][Full Text] [Related]
11. Clinical results with beta-methyl-p-(123I)iodophenylpentadecanoic acid, single-photon emission computed tomography in cardiac disease.
Nishimura T; Uehara T; Shimonagata T; Nagata S; Haze K
J Nucl Cardiol; 1994; 1(2 Pt 2):S65-71. PubMed ID: 9420700
[TBL] [Abstract][Full Text] [Related]
12. Myocardial scintigraphic study with 123I 15-(p-iodophenyl)-3(R,S)-methylpentadecanoic acid in patients with hypertrophic cardiomyopathy.
Shimizu M; Yoshio H; Ino H; Taki J; Nakajima K; Bunko H; Takeda R
Int J Cardiol; 1996 Apr; 54(1):51-9. PubMed ID: 8792185
[TBL] [Abstract][Full Text] [Related]
13. [The characteristic feature of myocardial imaging with 123I-labeled 15-(p-iodophenyl)-3R,S-methylpentadecanoic acid in hypertrophic cardiomyopathy with asymmetric septal hypertrophy].
Ohtsuki K; Sugihara H; Ito K; Matsumoto K; Taniguchi Y; Terada K; Nakagawa T; Shima T; Kuribayashi T; Ochiai M
Kaku Igaku; 1995 Apr; 32(4):377-85. PubMed ID: 7776544
[TBL] [Abstract][Full Text] [Related]
14. [Phase 2 study of beta-methyl-p-(123I)-iodophenyl-pentadecanoic acid, a myocardial imaging agent for evaluating myocardial fatty acid metabolism].
Torizuka K; Yonekura Y; Nishimura T; Tamaki N; Uehara T
Kaku Igaku; 1992 Mar; 29(3):305-17. PubMed ID: 1583804
[TBL] [Abstract][Full Text] [Related]
15. Clinical value of triple-energy window scatter correction in simultaneous dual-isotope single-photon emission tomography with 123I-BMIPP and 201Tl.
Yang JT; Yamamoto K; Sadato N; Tsuchida T; Takahashi N; Hayashi N; Yonekura Y; Ishii Y
Eur J Nucl Med; 1997 Sep; 24(9):1099-106. PubMed ID: 9283101
[TBL] [Abstract][Full Text] [Related]
16. Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy.
Kurata C; Tawarahara K; Taguchi T; Aoshima S; Kobayashi A; Yamazaki N; Kawai H; Kaneko M
J Nucl Med; 1992 Jan; 33(1):6-13. PubMed ID: 1530969
[TBL] [Abstract][Full Text] [Related]
17. Discrepancies between myocardial perfusion and free fatty acid metabolism in patients with hypertrophic cardiomyopathy.
Shimonagata T; Nishimura T; Uehara T; Hayashida K; Kumita S; Ohno A; Nagata S; Miyatake K
Nucl Med Commun; 1993 Nov; 14(11):1005-13. PubMed ID: 8290156
[TBL] [Abstract][Full Text] [Related]
18. Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy.
Tadamura E; Kudoh T; Hattori N; Inubushi M; Magata Y; Konishi J; Matsumori A; Nohara R; Sasayama S; Yoshibayashi M; Tamaki N
J Nucl Med; 1998 Mar; 39(3):390-6. PubMed ID: 9529280
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous dual myocardial imaging with iodine-123-beta-methyl iodophenyl-pentadecanoic acid (BMIPP) and thallium-201 in patients with coronary heart disease.
Tawarahara K; Kurata C; Taguchi T; Aoshima S; Okayama K; Kobayashi A; Yamazaki N; Kaneko M
Jpn Circ J; 1994 Feb; 58(2):107-15. PubMed ID: 8196152
[TBL] [Abstract][Full Text] [Related]
20. Comparison of myocardial fatty acid metabolism with left ventricular function and perfusion in cardiomyopathies: by 123I-BMIPP SPECT and 99mTc-tetrofosmin electrocardiographically gated SPECT.
Zhao C; Shuke N; Okizaki A; Yamamoto W; Sato J; Ishikawa Y; Ohta T; Hasebe N; Kikuchi K; Aburano T
Ann Nucl Med; 2003 Oct; 17(7):541-8. PubMed ID: 14651352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
